Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4g8c | C6L | Alpha/beta hydrolase fold protein |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4g8c | C6L | Alpha/beta hydrolase fold protein | / | 1.000 | |
4g8b | HL6 | Alpha/beta hydrolase fold protein | / | 0.544 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.499 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.480 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.477 | |
1zdw | FLV | Prenyltransferase | / | 0.472 | |
1upw | 444 | Oxysterols receptor LXR-beta | / | 0.471 | |
4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.470 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.469 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.469 | |
3ipq | 965 | Oxysterols receptor LXR-alpha | / | 0.467 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.466 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.465 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.465 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.464 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.464 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.463 | |
1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.463 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.463 | |
3gts | D3M | DdmC | / | 0.462 | |
3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.462 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.462 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.460 | |
3o57 | ZG2 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.460 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
2fm0 | M98 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.457 | |
2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.457 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.456 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.456 | |
4kp6 | 1S1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.456 | |
1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.454 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.454 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
1dr4 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
3c1o | NAP | Eugenol synthase | / | 0.452 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.452 | |
1pq6 | 965 | Oxysterols receptor LXR-beta | / | 0.451 | |
2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.450 | |
2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.450 | |
3b9l | AZZ | Serum albumin | / | 0.450 | |
3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.450 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
4n3r | 2GU | Tankyrase-1 | 2.4.2.30 | 0.450 | |
1ro6 | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.449 | |
1ve3 | SAM | Uncharacterized protein | / | 0.449 | |
1xe6 | 5FP | Plasmepsin-2 | 3.4.23.39 | 0.449 | |
3oad | LPO | Renin | 3.4.23.15 | 0.449 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.448 | |
3wi2 | P98 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.448 | |
3af1 | GDP | Pantothenate kinase | 2.7.1.33 | 0.447 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.447 | |
4e0u | 0MV | Cyclic dipeptide N-prenyltransferase | / | 0.447 | |
4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.447 | |
5std | UNN | Scytalone dehydratase | 4.2.1.94 | 0.447 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.446 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.446 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
3u8d | U8D | Phospholipase A2, membrane associated | / | 0.446 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.446 | |
4dvi | 2IW | Tankyrase-1 | 2.4.2.30 | 0.446 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
2bxq | IMN | Serum albumin | / | 0.445 | |
2geu | COK | Pantothenate kinase | 2.7.1.33 | 0.445 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
2xvv | 9DN | Serum albumin | / | 0.445 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.445 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.445 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.445 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
2zs8 | ADP | Pantothenate kinase | 2.7.1.33 | 0.444 | |
3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.444 | |
4gg1 | TZD | Benzoylformate decarboxylase | 4.1.1.7 | 0.444 | |
3g70 | A5T | Renin | 3.4.23.15 | 0.443 | |
3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.443 | |
4dbs | 0HV | Aldo-keto reductase family 1 member C3 | / | 0.443 | |
4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.443 | |
5irn | ADP | Nucleotide binding oligomerization domain containing 2 | / | 0.443 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.442 | |
3d3e | D3E | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3rsv | 3RS | Beta-secretase 1 | 3.4.23.46 | 0.442 | |
3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.442 | |
1a26 | CNA | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.441 | |
1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
1rpw | DID | HTH-type transcriptional regulator QacR | / | 0.441 | |
2vq7 | NAP | Putative flavin-containing monooxygenase | / | 0.441 | |
2zu9 | GDP | Mannosyl-3-phosphoglycerate synthase | 2.4.1.217 | 0.441 | |
3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.441 | |
3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.441 | |
3v94 | WYQ | Phosphodiesterase | / | 0.441 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
1xng | DND | NH(3)-dependent NAD(+) synthetase | 6.3.1.5 | 0.440 | |
1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.440 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2zev | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.440 | |
3af0 | GDP | Pantothenate kinase | 2.7.1.33 | 0.440 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 |